An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents

Clinical Cancer Research

Volumn 9, Issue 8, 2003, Pages 3012-3020

  Worrillow, Lisa J ^a   Travis, Lois B ^b   Smith, Alexandra G ^a   Rollinson, Sara ^a   Smith, Andrew J ^a   Wild, Christopher P ^a   Holowaty, Eric J ^c   Kohler, Betsy A ^d   Wiklund, Tom ^e   Pukkala, Eero ^f   Roman, Eve ^a   Morgan, Gareth J ^a   Allan, James M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CANCER CARE ONTARIO   (Canada)

^d NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUOROURACIL; HYDROXYUREA; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE;

ADULT; AGED; ALKYLATION; ALLELE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALKYLATING AGENTS; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA REPAIR; EXONS; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; LEUKEMIA; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 12444329767     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Kyle, R. A., Pierre, R. V., and Bayrd, E. D. Multiple myeloma and acute myelomonocytic leukaemia: a report of four cases possibly related to melphalan. N. Engl. J. Med., 283: 1121-1125, 1970.
2. Fisher, B., Rockette, H., Fisher, E. R., Wickerham, D. L. Redmond, C., and Brown, A. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J. Clin. Oncol., 3: 1640-1658, 1985.
3. Kaldor, J. M., Day, N. E., Pettersson, F., Pedersen, D., Mehnert, W., Bell, J., Host, H., Prior, P., and Karjalainen, S. Leukemia following chemotherapy for ovarian cancer. N. Engl. J. Med., 322: 1-6, 1990.
4. Travis, L. B., Curtis, R. E., Storm, H., Hall, P., Holowaty, E., Van Leeuwen, F. E., Kohler, B. A., Pukkala, E., Lynch, C. F., Andersson, M., Bergfeldt, K., Clarke, E. A., Wiklund, T., Stoter, G., Gospodarowicz, M., Sturgeon, J., Fraumeni, J. F., Jr., and Boice, J. D., Jr. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J. Natl. Cancer Inst. (Bethesda), 89: 1429-1439, 1997.
5. Travis, L. B., Holowaty, E., Hall, P., Bergfeldt, K. L., Charles, F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., Sturgeon, J., Stovall, M., Storm, H., Clarke, E. A., Boice, J. D. Jr., and Gospodarowicz, M. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N. Engl. J. Med., 340: 351-357, 1999.
6. Travis, L. B., Andersson, M., Gospodarowicz, M., van Leeuwen, F. E., Bergfeldt, K., Lynch, C. F., Curtis, R. E., Kohler, B. A., Wiklund, T., Storm, H., Holowaty, E., Hall, P., Pukkala, E., Sleijfer, D. T., Clarke, E. A., Stovall, M., and Gilbert, E. Treatment-associated leukemia following testicular cancer. J. Natl. Cancer Inst. (Bethesda), 92: 1165-1171, 2000.
7. Dores, G. M., Metayer, C., Curtis, R. E., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., van Leeuwen, F. E., Holowaty, E. J., Andersson, M., Wiklund, T., Joensuu, T., van't Veer, M. B., Stovall, M., Gospodarowicz, M., and Travis, L. B. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J. Clin. Oncol., 20: 3484-3494, 2002.
8. Felix, C. A. Secondary leukemias induced by topoisomerase targeted drugs. Biochim. Biophys. Acta, 1400: 233-255, 1998.
9. Le Beau, M. M., Albain, K. S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., Golomb, H. M., and Rowley, J. D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J. Clin. Oncol., 4: 325-345, 1986.
10. Leonard, D. G., Travis, L. B., Addya, K., Dores, G. M., Holowaty, E. J., Bergfeldt, K., Malkin, D., Kohler, B. A., Lynch, C. F., Wiklund, T., Stovall, M., Hall, P., Pukkala, Eslater, D. J., and Felix, C. A. p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer. Clin. Cancer Res., 8: 973-985, 2002.
11. Ben-Yehuda, D., Krichevsky, S., Caspi, O., Rund, D., Polliack, A., Abeliovich, D., Zelig, O., Yahalom, V., Paltiel, O., Or, R., Peretz, T., Ben-Neriah, S., Yehuda, O., and Rachmilewitz, E. A. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood, 88: 4296-4303, 1996.
12. Drummond, J. T., Li, G. M., Longley, M. J., and Modrich, P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science (Wash. DC), 268: 1909-1912, 1995.
13. Palombo, F., Iaccarino, I., Nakajima, E., Ikejima, M., Shimada, T., and Jiricny, J. hMutS β, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol., 6: 1181-1184, 1996.
14. Li, G. M., and Modrich, P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. USA, 92: 1950-1954, 1995.
15. Branch, P., Aquilina, G., Bignami, M., and Karran, P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature (Lond.), 362: 652-654, 1993.
16. Kat, A., Thilly, W. G., Fang, W. H., Longley, M. J., Li, G. M., and Modrich, P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA, 90: 6424-6428, 1993.
17. Papadopoulos, N., Nicolaides, N. C., Wei, Y. F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., and Adams, M. D. Mutation of a mutL homolog in hereditary colon cancer. Science (Wash. DC), 263: 1625-1629, 1994.
18. Boyer, J., Risinger, J., and Farber, R. A. Stability of microsatellites in myeloid neoplasias. Cancer Genet. Cytogenet., 106: 54-61, 1998.
19. Zhu, Y., Das-Gupta, E., and Russell, N. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukaemia. Blood, 94: 733-740, 1999.
20. Rimsza, L. M., Kopecky, K. J., Ruschulte, J., Chen, I. M., Slovak, M. L., Karanes, C., Godwin, J., List, A., and Willman, C. L. Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature. Leukemia (Baltimore), 14: 1044-1051, 2000.
21. Das-Gupta, E. P., Seedhouse, C. H., and Russell, N. H. Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br. J. Haematol., 114: 307-312, 2001.
22. Fishel, R., Lescoe, M. K., Rao, M. R., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodner, R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75: 1027-1038, 1993.
23. Lowsky, R., DeCoteau, J. F., Reitmair, A. H., Ichinohasama, R., Dong, W. F., Xu, Y., Mak, T. W., Kadin, M. E., and Minden, M. D. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood, 89: 2276-2282, 1997.
24. Brentnall, T. A., Rubin, C. E., Crispin, D. A., Stevens, A., Batchelor, R. H., Haggitt, R. C., Bronner, M. P., Evans, J. P., McCahill, L. E., and Bilir, N. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology, 109: 151-155, 1995.
25. Shapiro, M. B., and Senapathy, P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res., 15: 7155-7174, 1987.
26. Palicio, M., Blanco, I., Tortola, S., Gonzalez, I., Marcuello, E., Brunet, J., Lluis, F., Gonzalez-Aguilera, J. J., Peinado, M. A., and Capella, G. Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer. Br. J. Cancer, 82: 535-537, 2000.
27. Xia, L., Shen, W., Ritacca, F., Mitri, A., Madlensky, L., Berk, T., Cohen, Z., Gallinger, S., and Bapat, B. A truncated hMSH2 transcript occurs as a common variant in the population: implications for genetic diagnosis. Cancer Res., 56: 2289-2292, 1996.
28. Goessl, C., Plaschke, J., Pistorius, S., Hahn, M., Frank, S., Hampl, M., Gorgens, H., Koch, R., Saeger, H. D., and Schackert, H. K. An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer. Eur. J. Cancer, 33: 1869-1874, 1997.
29. Paz-y-Mino, C., Perez, J. C., Fiallo, B. F., and Leone, P. E. A polymorphism in the hMSH2 gene (gIVS12-6T>C) associated with non-Hodgkin lymphomas. Cancer Genet. Cytogenet., 133: 29-33, 2002.
30. Kane, E. V., Roman, E., Cartwright, R., Parker, J., and Morgan, G. Tobacco and the risk of acute leukaemia in adults. Br. J. Cancer, 81: 1228-1233, 1999.
31. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., and Goldstone, A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 92: 2322-2333, 1998.
32. Allan, J. M., Wild, C. P., Rollinson, S., Willett, E. V., Moorman, A. V., Dovey, G. J., Roddam, P. L., Roman, E., Cartwright, R. A., and Morgan, G. J. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc. Natl. Acad. Sci. USA, 98: 11592-11597, 2001.
33. Breslow, N. E., and Day, N. E. Statistical methods in cancer research: the analysis of case-control studies, Vol. 1, pp. 162-189. Lyon, France: International Agency for Research in Cancer, 1980.
34. Olipitz, W., Tilz, G. P., Beham-Schmid, C., Eibinger, C., Kerzina, P., and Sill, H. Microsatellite analysis in acute myeloid leukaemia evolving from myelodysplastic syndrome. Br. J. Haematol., 112: 248-249, 2001.
35. Koi, M., Umar, A., Chauhan, D. P., Cherian, S. P., Carethers, J. M., Kunkel, T. A., and Boland, C. R. Human-chromosome-3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon-tumor cells with homozygous hMLH1 mutation. Cancer Res., 54: 4308-4312, 1994.
36. Umar, A., Boyer, J. C., Thomas, D. C., Nguyen, D. C., Risinger, J. I., Boyd, J., Ionov, Y., Perucho, M., and Kunkel, T. A. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J. Biol. Chem., 269: 14367-14370, 1994.
37. Goldmacher, V. S., Cuzick, R. A., Jr., and Thilly, W. G. Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine. J. Biol. Chem., 261: 12462-12471, 1986.
38. Zhou, X. P., Hoang, J. M., Cottu, P., Thomas, G., and Hamelin, R. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene, 15: 1713-1718, 1997.
39. Hoang, J., Cottu, P. H., Thuille, B., Salmon, R. J., Thomas, G., and Hamelin, R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res., 57: 300-303, 1997.
40. Boland, C., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodriguez-Bigas, M. A., Fodde, R., Ranzani, G. N., and Srivastava, S. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58: 5248-5257, 1998.
41. Hickman, M. J., and Samson, L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA, 96: 10764-10769, 1999.
42. Toft, N. J., Winton, D. J., Kelly, J., Howard, L. A., Dekker, M., te Riele, H. Arends, M. J., Wyllie, A. H., Margison, G. P., and Clarke, A. R. Msh2 status modulates apoptosis and mutation frequency in the murine small intestine. Proc. Natl. Acad. Sci. USA, 96: 3911-3915, 1999.
43. Olipitz, W., Hopfinger, G., Aguiar R. C., Gunsilius, E., Girschkofsky, M., Bodner, C., Hiden K., Linkesch, W., Hoefler, G., and Sill, H. Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia. Genes Chromosomes Cancer, 34: 243-248, 2002.
44. Gafanovich, A., Ramu, N., Krichevsky, S., Pe'er, J., Amir, G., and Ben-Yehuda, D. Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms. Cancer (Phila.), 85: 504-510, 1999.
45. Halford, S., Sasieni, P., Rowan, A., Wasan, H., Bodmer, W., Talbot, I., Hawkins, N., Ward, R., and Tomlinson, I. Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res., 62: 53-57, 2002.
46. Andrew, S. E., McKinnon, M., Cheng, B. S., Francis, A., Penney, J., Reitmair, A. H., Mak, T. W., and Jirik, F. R. Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent. Proc. Natl. Acad. Sci. USA, 95: 1126-1130, 1998.
47. Colussi, C., Fiumicino, S., Giuliani, A., Rosini, S., Musiani, P., Macri, C., Potten, C. S., Crescenzi, M., and Bignami, M. 1, 2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice. J. Natl. Cancer Inst. (Bethesda), 93: 1534-1540, 2001.
48. Tasaka, T., Lee, S., Spira, S., Sasaki, K., Murata, M., Taoka, T., Ikeda, K., Tanaka, T., Takahara, J., and Irino, S. Infrequent microsatellite instability during the evolution of the myelodysplastic syndrome to acute myelocytic leukemia. Leukemia Res., 20: 113-117, 1996.
49. Abuin, A., Zhang, H. J., and Bradley, A. Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations Mol. Cell. Biol 20: 149-157 2000.
50. Fink, D., Nebel, S., Aebi, S., Nehme, A. and Howell, S. B. Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin and carboplatin. Int. J. Oncol., 11: 539-542, 1997.
51. DeWeese, T. L., Shipman, J. M. Larrier, N. A., Buckley, N. M., Buckley, N. M., Kidd, L. R., Groopman, J. D., Cutler, R. G., te Riele, H., and Nelson, W. G. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally tom oxidative stress inflicted by low-level radiation. Proc. Natl. Acad. Sci. USA, 95: 11915-11920, 1998.